Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
Clinical trial NCT04676867 · COMPLETED
Trial details
- NCT number
- NCT04676867
- Sponsor
- DalCor Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-05-17
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.